Cytomegalovirus Vaccine
Showing 1 - 25 of 8,665
Cytomegalovirus Infections Trial in Manchester (SPYVAC01)
Not yet recruiting
- Cytomegalovirus Infections
- SPYVAC01
-
Manchester, United KingdomMedicines Evaluation Unit
Nov 20, 2023
Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)
Not yet recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 4, 2023
Cytomegalovirus Infection Trial in North Hollywood, San Diego, Honolulu (mRNA-1647, Placebo)
Active, not recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
North Hollywood, California
- +2 more
Dec 3, 2022
Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)
Completed
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Sacramento, California
- +8 more
Jan 11, 2023
Glioblastoma Trial (PEP-CMV vaccine)
Not yet recruiting
- Glioblastoma
- PEP-CMV vaccine
- (no location specified)
Nov 9, 2023
Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)
Not yet recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Birmingham, Alabama
- +25 more
Nov 10, 2023
Cytomegalovirus Infections Trial in Fukuoka (V160, Placebo)
Completed
- Cytomegalovirus Infections
- V160
- Placebo
-
Fukuoka, JapanSouseikai PS Clinic ( Site 0001)
Nov 19, 2021
Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell
Not yet recruiting
- Cytomegaloviral Infection
- Hematopoietic and Lymphoid System Neoplasm
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 16, 2022
Cytomegalovirus Infections Trial in United States (Pentamer (low)/gB(low)/Adjuvant vaccine, Pentamer (med)/gB(low)/Adjuvant
Recruiting
- Cytomegalovirus Infections
- Pentamer (low)/gB(low)/Adjuvant vaccine
- +4 more
-
Long Beach, California
- +14 more
Jul 15, 2022
Cytomegalovirus Infections Trial (V160 Low Dose IM, V160 Medium Dose IM, V160 High Dose IM)
Completed
- Cytomegalovirus Infections
- V160 Low Dose IM
- +8 more
- (no location specified)
Sep 30, 2021
Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide
Recruiting
- Cytomegaloviral Infection
- Hematopoietic Cell Transplant Recipient
- Laboratory Biomarker Analysis
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
Liver Transplant Trial in United States (CMV-MVA Triplex, Placebo for CMV-MVA Triplex)
Not yet recruiting
- Liver Transplant
- CMV-MVA Triplex
- Placebo for CMV-MVA Triplex
-
Redwood City, California
- +16 more
Oct 10, 2023
Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)
Recruiting
- Cytomegalovirus Infections
- +2 more
- CMV-MVA Triplex
- Placebo
-
Birmingham, Alabama
- +11 more
Jun 20, 2022
Cytomegalovirus Infections, Influenza Trial in Stanford (Fluzone® 2012-2013 Formula NDC No 498281-012-50)
Completed
- Cytomegalovirus Infections
- Influenza
- Fluzone® 2012-2013 Formula NDC No 498281-012-50
-
Stanford, CaliforniaStanford University School of Medicine
Sep 21, 2021
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +13 more
- CMVpp65-A*0201 peptide vaccine
- +2 more
-
Duarte, California
- +4 more
Jan 4, 2023
Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria
Suspended
- Glioblastoma
- Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Cytomegalovirus Infection Trial in United States (DBS Self-Collection Kit, Standard Control Strategy)
Recruiting
- Cytomegalovirus Infection
- DBS Self-Collection Kit
- Standard Control Strategy
-
Minneapolis, Minnesota
- +3 more
Aug 18, 2022
Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous
Active, not recruiting
- Malignant Neoplasms of Brain
- tetanus toxoid
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Cytomegalovirus Trial in Canada, United Kingdom, United States (mRNA-1647, Placebo)
Recruiting
- Cytomegalovirus
- mRNA-1647
- Placebo
-
La Mesa, California
- +60 more
Jan 12, 2023
Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed
Completed
- Glioblastoma
- +3 more
- Unpulsed DCs
- +6 more
-
Durham, North CarolinaDuke University Medical Center
Jan 3, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
Cytomegalovirus Infections Trial in Vancouver, Halifax, Pierrefonds (VBI-1501A 0.5 µg, VBI-1501A 1.0 µg, VBI-1501A 2.0 µg)
Completed
- Cytomegalovirus Infections
- VBI-1501A 0.5 μg
- +4 more
-
Vancouver, British Columbia, Canada
- +2 more
Apr 16, 2020
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Cytomegalovirus Infection Trial in Worldwide (mRNA-1647, Placebo)
Recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Phoenix, Arizona
- +165 more
Jan 13, 2023
Malignant Tumors Brain Trial in Durham (RNA-loaded dendritic cell vaccine, basiliximab)
Completed
- Malignant Neoplasms Brain
- RNA-loaded dendritic cell vaccine
- basiliximab
-
Durham, North CarolinaDuke University Medical Center
Mar 8, 2021